Targeting cancer stem cells in refractory cancer

Although common cancer therapies, such as chemotherapy and radiation therapy, have recently improved and yielded good results, evaluated as tumor shrinkage, disease recurrence is still a common event for most cancer patients. This is termed refractory cancer. This tumor regrowth following therapy is...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyoshi, Norikatsu, Haraguchi, Naotsugu, Mizushima, Tsunekazu, Ishii, Hideshi, Yamamoto, Hirofumi, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868918/
https://www.ncbi.nlm.nih.gov/pubmed/33598510
http://dx.doi.org/10.1016/j.reth.2021.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868918/
https://www.ncbi.nlm.nih.gov/pubmed/33598510
http://dx.doi.org/10.1016/j.reth.2021.01.002

Ejemplares similares